Treatment With Long Acting GnRH Antagonist Degarelix in Women With Endometriosis Recurrence

Trial Profile

Treatment With Long Acting GnRH Antagonist Degarelix in Women With Endometriosis Recurrence

Completed
Phase of Trial: Phase III

Latest Information Update: 29 Apr 2016

At a glance

  • Drugs Degarelix (Primary) ; Goserelin
  • Indications Endometriosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 25 Apr 2016 Status changed from recruiting to completed.
    • 02 Dec 2013 Planned end date changed from 1 Oct 2013 to 1 Oct 2014 as reported by ClinicalTrials.gov.
    • 29 Nov 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top